Progenics Pharma (PGNX) Posts Q4 Loss of 14c/Share
Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) reported Q4 EPS of ($0.14) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)